Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulationYifat Geffen, Antonio Colaprico, Liang-Bo Wang et al.|Cell|2023Cited by 190
Pan-cancer proteogenomics connects oncogenic drivers to functional statesYize Li, Li Ding, Eduard Porta‐Pardo et al.|Cell|2023Cited by 104
Pan-cancer proteogenomics characterization of tumor immunityFrancesca Petralia, Zeynep H. Gümüş, Weiping Ma et al.|Cell|2024Cited by 91
The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitroTomer M. Yaron, Nicholas S. Heaton|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 63
Parallel phosphoproteomics and metabolomics map the global metabolic tyrosine phosphoproteomeAlissandra L. Hillis, Alex Toker, Tigist Y. Tamir et al.|Proceedings of the National Academy of Sciences|2024Cited by 6